XXEC Inc. Has $20.46 Million Position in Xylem Inc. $XYL

XXEC Inc. increased its stake in shares of Xylem Inc. (NYSE:XYL) by 477.9% during the 1st quarter, Holdings Channel reports. The fund owned 171,211 shares of the industrial products company’s stock after acquiring an additional 141,586 shares during the period. Xylem comprises approximately 4.0% of XXEC Inc.’s investment portfolio, making the stock its 12th largest position. XXEC Inc.’s holdings in Xylem were worth $20,460,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also bought and sold shares of the company. Knuff & Co LLC acquired a new position in shares of Xylem during the third quarter valued at about $27,000. Board of the Pension Protection Fund bought a new position in shares of Xylem during the 4th quarter worth about $27,000. Commonwealth Retirement Investments LLC acquired a new stake in shares of Xylem in the 4th quarter valued at about $27,000. Wexford Capital LP acquired a new stake in shares of Xylem in the 3rd quarter valued at about $27,000. Finally, Ramirez Asset Management Inc. increased its position in Xylem by 100.0% in the 3rd quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock valued at $30,000 after buying an additional 100 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Xylem

In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the sale, the chief accounting officer directly owned 3,605 shares of the company’s stock, valued at approximately $423,443.30. This represents a 54.22% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Jerome A. Peribere acquired 1,210 shares of the company’s stock in a transaction on Monday, May 4th. The shares were bought at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the purchase, the director owned 27,209 shares in the company, valued at approximately $3,172,841.49. This represents a 4.65% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.32% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on XYL. Jefferies Financial Group upgraded Xylem from a “hold” rating to a “buy” rating and increased their price target for the stock from $130.00 to $140.00 in a report on Thursday, June 25th. Barclays decreased their price objective on Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a report on Wednesday, April 29th. JPMorgan Chase & Co. lowered their target price on Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a research report on Thursday, April 16th. Weiss Ratings cut Xylem from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, May 8th. Finally, UBS Group lifted their price target on shares of Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Eight equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, Xylem presently has an average rating of “Moderate Buy” and a consensus price target of $153.54.

Xylem Price Performance

Shares of NYSE XYL opened at $118.23 on Wednesday. The stock has a market cap of $28.10 billion, a price-to-earnings ratio of 29.41, a PEG ratio of 1.66 and a beta of 1.04. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. Xylem Inc. has a fifty-two week low of $105.29 and a fifty-two week high of $154.27. The firm’s 50-day simple moving average is $112.82 and its 200 day simple moving average is $125.00.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. The firm had revenue of $2.12 billion during the quarter, compared to analyst estimates of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The company’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the previous year, the company posted $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, research analysts anticipate that Xylem Inc. will post 5.51 earnings per share for the current fiscal year.

Xylem Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were issued a dividend of $0.43 per share. The ex-dividend date was Thursday, May 28th. This represents a $1.72 annualized dividend and a yield of 1.5%. Xylem’s dividend payout ratio is 42.79%.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.